Copyright Reports & Markets. All rights reserved.

Global Anti-inflammatory Drugs Market Research Report 2019 by Manufacturers, Regions, Types and Applications

Buy now

Table of Contents

    1 Executive Summary

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Anti-inflammatory Drugs Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 by Types
      • 2.1.2 Over-The-Counter
      • 2.1.3 Prescription Medications
      • 2.1.4 by Products
      • 2.1.5 Aspirin,
      • 2.1.6 Ibuprofen
      • 2.1.7 Naproxen
      • 2.1.8 COX-2 Inhibitors
      • 2.1.9 Other
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 by Types
      • 2.2.2 Over-The-Counter
      • 2.2.3 Prescription Medications
      • 2.2.4 by Products
      • 2.2.5 Aspirin,
      • 2.2.6 Ibuprofen
      • 2.2.7 Naproxen
      • 2.2.8 COX-2 Inhibitors
      • 2.2.9 Other

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Skin Rashes
      • 3.1.2 Chronic Arthritis
      • 3.1.3 Other

    4 Manufacturers Profiles/Analysis

    • 4.1 Roche
      • 4.1.1 Roche Profiles
      • 4.1.2 Roche Product Information
      • 4.1.3 Roche Anti-inflammatory Drugs Sales, Sales Value(Million USD), Price and Gross Profit
      • 4.1.4 Roche SWOT Analysis
    • 4.2 Abbott Laboratories
      • 4.2.1 Abbott Laboratories Profiles
      • 4.2.2 Abbott Laboratories Product Information
      • 4.2.3 Abbott Laboratories Anti-inflammatory DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.2.4 Abbott Laboratories SWOT Analysis
    • 4.3 Johnson & Johnson
      • 4.3.1 Johnson & Johnson Profiles
      • 4.3.2 Johnson & Johnson Product Information
      • 4.3.3 Johnson & Johnson Anti-inflammatory DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.3.4 Johnson & Johnson SWOT Analysis
    • 4.4 Merck & Co.
      • 4.4.1 Merck & Co. Profiles
      • 4.4.2 Merck & Co. Product Information
      • 4.4.3 Merck & Co. Anti-inflammatory DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.4.4 Merck & Co. SWOT Analysis
    • 4.5 Pfizer
      • 4.5.1 Pfizer Profiles
      • 4.5.2 Pfizer Product Information
      • 4.5.3 Pfizer Anti-inflammatory DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.5.4 Pfizer SWOT Analysis
    • 4.6 Amgen
      • 4.6.1 Amgen Profiles
      • 4.6.2 Amgen Product Information
      • 4.6.3 Amgen Anti-inflammatory DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.6.4 Amgen SWOT Analysis
    • 4.7 Sanofi
      • 4.7.1 Sanofi Profiles
      • 4.7.2 Sanofi Product Information
      • 4.7.3 Sanofi Anti-inflammatory DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.7.4 Sanofi SWOT Analysis
    • 4.8 Novartis
      • 4.8.1 Novartis Profiles
      • 4.8.2 Novartis Product Information
      • 4.8.3 Novartis Anti-inflammatory DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.8.4 Novartis SWOT Analysis
    • 4.9 Eli Lilly
      • 4.9.1 Eli Lilly Profiles
      • 4.9.2 Eli Lilly Product Information
      • 4.9.3 Eli Lilly Anti-inflammatory DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.9.4 Eli Lilly SWOT Analysis
    • 4.10 Amgen
      • 4.10.1 Amgen Profiles
      • 4.10.2 Amgen Product Information
      • 4.10.3 Amgen Anti-inflammatory DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.10.4 Amgen SWOT Analysis
    • 4.11 Bayer
    • 4.12 Novacap
    • 4.13 Kopran Ltd.

    5 Market Performance for Manufacturers

    • 5.1 Global Anti-inflammatory Drugs Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Global Anti-inflammatory Drugs Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Global Anti-inflammatory Drugs Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Global Anti-inflammatory Drugs Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Anti-inflammatory Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 China Anti-inflammatory Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 China Anti-inflammatory Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 China Anti-inflammatory Drugs Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Anti-inflammatory Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 USA Anti-inflammatory Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 USA Anti-inflammatory Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 USA Anti-inflammatory Drugs Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Anti-inflammatory Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 Europe Anti-inflammatory Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 Europe Anti-inflammatory Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 Europe Anti-inflammatory Drugs Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Anti-inflammatory Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Japan Anti-inflammatory Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Japan Anti-inflammatory Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Japan Anti-inflammatory Drugs Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Anti-inflammatory Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Korea Anti-inflammatory Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Korea Anti-inflammatory Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Korea Anti-inflammatory Drugs Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Anti-inflammatory Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 India Anti-inflammatory Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 India Anti-inflammatory Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 India Anti-inflammatory Drugs Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Anti-inflammatory Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Southeast Asia Anti-inflammatory Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Southeast Asia Anti-inflammatory Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Southeast Asia Anti-inflammatory Drugs Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Anti-inflammatory Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 South America Anti-inflammatory Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 South America Anti-inflammatory Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 South America Anti-inflammatory Drugs Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Global Anti-inflammatory Drugs Market Assessment by Regions (2014-2020)

    • 7.1 Global Anti-inflammatory Drugs Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Global Anti-inflammatory Drugs Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Global Anti-inflammatory Drugs Price (USD/Unit) by Regions 2014-2020
    • 7.4 Global Anti-inflammatory Drugs Gross Margin by Regions 2014-2020

    8 Development Trend for Regions

    • 8.1 Global Anti-inflammatory Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.2 China Anti-inflammatory Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.3 USA Anti-inflammatory Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 Europe Anti-inflammatory Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.5 Japan Anti-inflammatory Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.6 Korea Anti-inflammatory Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.7 India Anti-inflammatory Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Anti-inflammatory Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Anti-inflammatory Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Manufacturing Plants Distribution

    11 Consumer Analysis

    • 11.1 Skin Rashes Industry
    • 11.2 Chronic Arthritis Industry
    • 11.3 Other Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Global Anti-inflammatory Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Global Anti-inflammatory Drugs Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 China Anti-inflammatory Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 USA Anti-inflammatory Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 Europe Anti-inflammatory Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Japan Anti-inflammatory Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Korea Anti-inflammatory Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 India Anti-inflammatory Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Southeast Asia Anti-inflammatory Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.10 South America Anti-inflammatory Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 by Types
      • 12.2.3 Over-The-Counter
      • 12.2.4 Prescription Medications
      • 12.2.5 by Products
      • 12.2.6 Aspirin,
      • 12.2.7 Ibuprofen
      • 12.2.8 Naproxen
      • 12.2.9 COX-2 Inhibitors
      • 12.2.10 Other
    • 12.3 Sales (K Units) Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Skin Rashes
      • 12.3.3 Chronic Arthritis
      • 12.3.4 Other
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Anti-inflammatory Drugs Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Global Anti-inflammatory Drugs Gross Profit Trend 2021-2026

    13 Conclusion

    According to XYZResearch study, over the next five years the Anti-inflammatory Drugsmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Anti-inflammatory Drugsbusiness.
    Anti-inflammatory Drugs market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
    Sales forecast by type/application from 2021-2026
    Industry chain, downstream and upstream information is also included.
    World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
    Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO. The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
    XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

    This report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Anti-inflammatory Drugs for these regions, from 2014 to 2026 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    Global Anti-inflammatory Drugs market competition by top manufacturers/players, with Anti-inflammatory Drugs sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    Roche
    Abbott Laboratories
    Johnson & Johnson
    Merck & Co.
    Pfizer
    Amgen
    Sanofi
    Novartis
    Eli Lilly
    Amgen
    Bayer
    Novacap
    Kopran Ltd.
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    by Types
    Over-The-Counter
    Prescription Medications
    by Products
    Aspirin,
    Ibuprofen
    Naproxen
    COX-2 Inhibitors
    Other
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Anti-inflammatory Drugs for each application, including
    Skin Rashes
    Chronic Arthritis
    Other

    Feel free to let me know if you have any special requirements.

    Buy now